MCID: VSC003
MIFTS: 50

Visceral Leishmaniasis malady

Infectious diseases category

Aliases & Classifications for Visceral Leishmaniasis

About this section
Sources:
9Disease Ontology, 11DISEASES, 43Novoseek, 3CDC, 60UMLS, 33MeSH, 27ICD9CM, 38NCIt, 55SNOMED-CT, 25ICD10
See all sources

Visceral Leishmaniasis, Aliases & Descriptions:

Name: Visceral Leishmaniasis 9 11
Kala-Azar 9 3
Infection by Visceral Leishmaniasis 9
 
Leishmaniasis, Visceral 60
Leishmaniasis Visceral 43


Classifications:

Malacards categories (disease lists): (See all malacards categories)
Global: Infectious diseases


External Ids:

Disease Ontology9 DOID:9146
MeSH33 D007898
ICD9CM27 085.0
SNOMED-CT55 186803007, 48115004
NCIt38 C34771
ICD1025 B55.0, B55.9

Summaries for Visceral Leishmaniasis

About this section


CDC:3 Leishmaniasis is a parasitic disease that is found in parts of the tropics, subtropics, and southern Europe. It is classified as a Neglected Tropical Disease (NTD). Leishmaniasis is caused by infection with Leishmania parasites, which are spread by the bite of phlebotomine sand flies. There are several different forms of leishmaniasis in people. The most common forms are cutaneous leishmaniasis, which causes skin sores, and visceral leishmaniasis, which affects several internal organs (usually spleen, liver, and bone marrow).

MalaCards based summary: Visceral Leishmaniasis, also known as kala-azar, is related to leishmaniasis and leprosy. An important gene associated with Visceral Leishmaniasis is SLC11A1 (solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1), and among its related pathways are African trypanosomiasis and Cytokines and Inflammatory Response. The drugs meglumine and pentamidine and the compounds betaseron and interferon gamma have been mentioned in the context of this disorder. Affiliated tissues include bone marrow, bone and liver, and related mouse phenotypes are digestive/alimentary and normal.

Disease Ontology:9 A leishmaniasis that is the most severe form of the disease caused by protozoan parasites of the leishmania genus, resulting in the infection of the internal organs such as liver, spleen and bone marrow. the symptoms include fever, weight loss, and an enlarged spleen and liver.

Wikipedia:63 Visceral leishmaniasis (VL), also known as kala-azar, black fever, and Dumdum fever, is the most severe... more...

Related Diseases for Visceral Leishmaniasis

About this section

Diseases related to Visceral Leishmaniasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 119)
idRelated DiseaseScoreTop Affiliating Genes
1leishmaniasis32.5SLC11A1, IL10, IFNG
2leprosy31.6SLC11A1
3cutaneous leishmaniasis31.1IL10, IFNG
4malaria31.0IL10, IFNG
5tuberculoid leprosy30.8IFNG, IL10
6lepromatous leprosy30.8IFNG, IL10
7arthritis30.6CXCR1, IFNG, IL10, SLC11A1
8lymphopenia30.5IFNG, IL10
9uveitis30.5IL10, IFNG, CXCR1
10tuberculosis30.2SLC11A1, IL10, IFNG, CXCR1
11psoriasis29.8CXCR1, IFNG, IL10, IL10RA
12systemic lupus erythematosus29.6IL10RA, IL10, IL21, IFNG
13rheumatoid arthritis29.5CXCR1, IFNG, IL21, IL10, IL10RA, SLC11A1
14hemophagocytic lymphohistiocytosis10.6
15splenomegaly10.5
16hiv-110.5
17pancytopenia10.5
18hepatitis10.4
19chagas disease10.4
20immune-complex glomerulonephritis10.4
21autoimmune hepatitis10.4
22glomerulonephritis10.4
23inflammatory bowel disease10.3IL10
24chronic granulomatous disease10.3
25leukemia10.3
26cryoglobulinemia10.3
27acquired immunodeficiency syndrome10.3
28malignant histiocytosis10.3
29cervicitis10.3
30connective tissue disease10.3
31histiocytosis10.3
32strongyloidiasis10.3
33leptospirosis10.3
34indeterminate leprosy10.3
35mucocutaneous leishmaniasis10.3
36felty's syndrome10.3
37paronychia10.3
38disseminated intravascular coagulation10.3
39relapsing fever10.3
40syphilis10.3
41toxoplasmosis10.3
42anterior uveitis10.3
43macroglossia10.3
44leukopenia10.3
45relapsing-remitting multiple sclerosis10.2IFNG, IL10
46acute graft versus host disease10.2IL10, IFNG
47demyelinating disease10.2IFNG, IL10
48diabetes mellitus, insulin-dependent10.2IL10, IFNG
49plasmodium falciparum malaria10.2IL10, IFNG
50schistosomiasis10.2IL10, IFNG

Graphical network of the top 20 diseases related to Visceral Leishmaniasis:



Diseases related to visceral leishmaniasis

Symptoms for Visceral Leishmaniasis

About this section

Drugs & Therapeutics for Visceral Leishmaniasis

About this section

Drug clinical trials:

Search ClinicalTrials for Visceral Leishmaniasis

Search NIH Clinical Center for Visceral Leishmaniasis

Inferred drug relations via UMLS60/NDF-RT39:

Genetic Tests for Visceral Leishmaniasis

About this section

Anatomical Context for Visceral Leishmaniasis

About this section

MalaCards organs/tissues related to Visceral Leishmaniasis:

31
Bone marrow, Bone, Liver, Spleen, Testes, Skin, T cells, Kidney, Monocytes, Whole blood, Brain, B cells, Lymph node, Smooth muscle, Pancreas

Animal Models for Visceral Leishmaniasis or affiliated genes

About this section

MGI Mouse Phenotypes related to Visceral Leishmaniasis:

35
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053818.5SLC11A1, DLL1, IL10RA, IL10, IFNG
2MP:00028737.9DLL1, IL10, IL21, IFNG, CXCR1
3MP:00053977.8IFNG, IL21, IL10, IL10RA, DLL1, SLC11A1
4MP:00053877.6IFNG, IL21, IL10, IL10RA, DLL1, SLC11A1

Publications for Visceral Leishmaniasis

About this section

Articles related to Visceral Leishmaniasis:

(show top 50)    (show all 684)
idTitleAuthorsYear
1
Epidemiological aspects of vector, parasite, and domestic reservoir in areas of recent transmission and no reported human cases of visceral leishmaniasis in Brazil. (25882769)
2015
2
Evaluation of the immunoprophylactic potential of a killed vaccine candidate in combination with different adjuvants against murine visceral leishmaniasis. (25316605)
2014
3
Visceral leishmaniasis in Brazil: rationale and concerns related to reservoir control. (25372177)
2014
4
Experimental infection of dogs with Leishmania and saliva as a model to study Canine Visceral Leishmaniasis. (23577121)
2013
5
Role of fine-needle aspiration cytology in the prompt diagnosis of recurrence of visceral leishmaniasis presented as isolated cervical leishmanial lymphadenopathy. (21671412)
2013
6
Association of interleukin-18 gene variants with susceptibility to visceral leishmaniasis in Iranian population. (23269628)
2013
7
Validation of a direct agglutination test prototype kit for the diagnosis of visceral leishmaniasis. (23382276)
2013
8
Diagnosis of visceral leishmaniasis in Bihar India: comparison of the rK39 rapid diagnostic test on whole blood versus serum. (23717700)
2013
9
Visceral leishmaniasis with associated immune dysregulation leading to lymphoma. (23707131)
2013
10
Identification of environmental parameters and risk mapping of visceral leishmaniasis in Ethiopia by using geographical information systems and a statistical approach. (23733292)
2013
11
Adherence to miltefosine treatment for visceral leishmaniasis under routine conditions in Nepal. (23199340)
2013
12
Cationic solid-lipid nanoparticles are as efficient as electroporation in DNA vaccination against visceral leishmaniasis in mice. (23710803)
2013
13
Factors associated with asymptomatic infection in family members and neighbors of patients with visceral leishmaniasis. (23288063)
2012
14
Killed but metabolically active Leishmania infantum as a novel whole-cell vaccine for visceral leishmaniasis. (22323556)
2012
15
Prevalence, features and risk factors for malaria co-infections amongst visceral leishmaniasis patients from Amudat Hospital, Uganda. (22506087)
2012
16
Comparative study of rK39 Leishmania antigen for serodiagnosis of visceral leishmaniasis: systematic review with meta-analysis. (22303488)
2012
17
Recent advances in development of amphotericin B formulations for the treatment of visceral leishmaniasis. (23147810)
2012
18
Resistance to visceral leishmaniasis is severely compromised in mice deficient of bradykinin B2-receptors. (23151408)
2012
19
Asymptomatic carriage of Leishmania in family members of patients with visceral leishmaniasis in Central Tunisia. (22154335)
2012
20
The economic value of a visceral leishmaniasis vaccine in Bihar state, India. (22403311)
2012
21
Making an anti-amastigote vaccine for visceral leishmaniasis: rational, update and perspectives. (22698479)
2012
22
Evaluation of serological cross-reactivity between canine visceral leishmaniasis and natural infection by Trypanosoma caninum. (22840335)
2012
23
Leishmania chagasi naturally resistant to nitric oxide isolated from humans and dogs with visceral leishmaniasis in Brazil. (22580230)
2012
24
Sialoglycosylation of RBC in visceral leishmaniasis leads to enhanced oxidative stress, calpain-induced fragmentation of spectrin and hemolysis. (22860118)
2012
25
Insecticide susceptibility status of Phlebotomus argentipes, a vector of visceral leishmaniasis in different foci in three states of India. (23428526)
2012
26
Genetic markers for SSG resistance in Leishmania donovani and SSG treatment failure in visceral leishmaniasis patients of the Indian subcontinent. (22753945)
2012
27
Burden of visceral leishmaniasis in villages of eastern Gedaref State, Sudan: an exhaustive cross-sectional survey. (23133683)
2012
28
Visceral Leishmaniasis Eradication is a Reality: Data from a Community-based Active Surveillance in Bangladesh. (23532674)
2012
29
Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use. (22573856)
2012
30
Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood. (22539471)
2012
31
Ecological aspects of phlebotomines (Diptera: Psychodidae) in endemic area of visceral leishmaniasis, Campo Grande, State of Mato Grosso do Sul, Brazil. (22308770)
2012
32
IL-27 and IL-21 are associated with T cell IL-10 responses in human visceral leishmaniasis. (21357266)
2011
33
Case report: Acute renal injury as a result of liposomal amphotericin B treatment in sodium stibogluconate unresponsive visceral leishmaniasis. (22144439)
2011
34
Role of leptin in human visceral leishmaniasis? (21724337)
2011
35
Uncoupling protein 2 negatively regulates mitochondrial reactive oxygen species generation and induces phosphatase-mediated anti-inflammatory response in experimental visceral leishmaniasis. (21705615)
2011
36
Will visceral leishmaniasis be eliminated from Nepal? A review of recent (1994-2006) control efforts. (22808821)
2011
37
Visceral leishmaniasis and arsenic: an ancient poison contributing to antimonial treatment failure in the Indian subcontinent? (21980542)
2011
38
Clinical expression of autoimmune hepatitis in a nine-year-old girl with visceral leishmaniasis. (21866471)
2011
39
Canine visceral leishmaniasis: study of methods for the detection of IgG in serum and eluate samples. (21748226)
2010
40
Study of sand fly fauna in an endemic area of American cutaneous leishmaniasis and canine visceral leishmaniasis in the municipality of EspA-rito Santo do Pinhal, SALo Paulo, Brazil. (20428683)
2010
41
CD 28 gene polymorphism and plasma concentration of soluble CD 28 in Iranian patients with visceral leishmaniasis. (20962715)
2010
42
Anti-iL-10 mAb protection against experimental visceral leishmaniasis via induction of Th1 cytokines and nitric oxide. (19634715)
2009
43
Cerebrospinal fluid involvement in a case of visceral leishmaniasis associated with hemophagocytic lymphohistiocytosis. (21748112)
2007
44
The epidemiology of visceral leishmaniasis and asymptomatic leishmanial infection in a highly endemic Bangladeshi village. (17488915)
2007
45
Adenosine deaminase activity in sera of patients with visceral leishmaniasis in Nepal. (15970028)
2005
46
Oxidative stress and non-enzymatic antioxidative status in dogs with visceral Leishmaniasis. (15120954)
2004
47
Elevated plasma levels of interferon (IFN)-gamma, IFN-gamma inducing cytokines, and IFN-gamma inducible CXC chemokines in visceral leishmaniasis. (15569785)
2004
48
Splenomegaly in Baringo District, Kenya, an area endemic for visceral leishmaniasis and malaria. (7483000)
1995
49
Diffuse nodular regenerative hyperplasia of the liver associated with human immunodeficiency virus and visceral leishmaniasis. (8438854)
1993
50
Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma. (2104665)
1990

Variations for Visceral Leishmaniasis

About this section

Expression for genes affiliated with Visceral Leishmaniasis

About this section
Search GEO for disease gene expression data for Visceral Leishmaniasis.

Pathways for genes affiliated with Visceral Leishmaniasis

About this section

Pathways related to Visceral Leishmaniasis according to GeneCards Suite gene sharing:

(show all 17)
idSuper pathways (with members indented)ScoreTop Affiliating Genes
19.7IL10, IFNG
29.7IL10, IFNG
3
Show member pathways
9.7IFNG, IL10
49.7IFNG, IL10
59.7IFNG, IL10
6
Show member pathways
IL27-mediated signaling events36
9.7IFNG, IL10
79.7IFNG, IL10
89.5IL10RA, IL10
9
Show member pathways
9.5IFNG, IL21
10
Show member pathways
IL23-mediated signaling events36
Immune response IL 10 signaling pathway58
Angiopoietin receptor Tie2-mediated signaling36
Development PDGF signaling via STATs and NF kB58
Development Angiopoietin Tie2 signaling58
9.2IFNG, IL10, IL10RA
119.2IFNG, IL10, IL10RA
128.7IL10, IL10RA, IFNG, HSPA1L
13
Show member pathways
8.7HSPA1L, IFNG, IL10, IL10RA
14
Show member pathways
8.6IL10RA, IL10, IL21, DLL1
15
Show member pathways
Type III interferon signaling36
8.5IL10, IL21, IFNG, IL10RA
16
Show member pathways
8.1IL10RA, HSPA1L, IFNG, IL21, IL10
17
Show member pathways
7.7IL21, CXCR1, IFNG, IL10, IL10RA

Compounds for genes affiliated with Visceral Leishmaniasis

About this section

Compounds related to Visceral Leishmaniasis according to GeneCards Suite gene sharing:

(show all 36)
idCompoundScoreTop Affiliating Genes
1betaseron4310.1IL10, IFNG
2interferon gamma4310.1IL10, IFNG
3alpha-galactosylceramide4310.1IFNG, IL10
4glatiramer acetate43 1211.1IL10, IFNG
5tuberculin4310.1IL10, IFNG
6natalizumab43 1211.1IFNG, IL10
7il-124310.1IL10, IFNG
8adalimumab43 49 1212.0IL10, IFNG
9indoleamine4310.0IFNG, IL10
10imiquimod43 59 28 1213.0IL10, IFNG
11polymyxin b4310.0IFNG, IL10
12citrulline43 2411.0IL10, IFNG
13okt34310.0IFNG, IL10
14gm-csf43 2811.0IL10, IFNG
152,5-oligoadenylate4310.0IFNG, IL10
16polyinosinic-polycytidylic acid4310.0IFNG, IL10
17rolipram43 59 2812.0IL10, IFNG
18etanercept43 49 1211.9IL10, IFNG
19mycophenolate mofetil43 49 1211.9IL10, IFNG
20infliximab43 49 1211.9IFNG, IL10
21ivig439.9IL10, IFNG
22ribavirin43 49 1211.9IL10, IFNG
23pentoxifylline43 1210.8IFNG, IL10
24ifn-alpha439.8IL10, IFNG
25neopterin439.8IFNG, IL10
2615-deoxy-delta-12,14-prostaglandin j2439.7IL10, IFNG
27thalidomide43 49 59 1212.7IL10, IFNG
28allergens439.6IL10, IFNG
29il 10439.6IL10RA, IL10, IFNG
30groalpha439.6CXCR1, IL10
31con a439.5IL10, IL21, IFNG
32tarc439.3CXCR1, IFNG, IL10
33ccl343 2810.3IL10, IFNG, CXCR1
34endotoxin439.3IL10, IFNG, CXCR1
35rantes438.7CXCR1, IFNG, IL21, IL10
36cycloheximide438.6CXCR1, IFNG, IL10

GO Terms for genes affiliated with Visceral Leishmaniasis

About this section

Biological processes related to Visceral Leishmaniasis according to GeneCards Suite gene sharing:

(show all 11)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of MHC class II biosynthetic processGO:00453489.9IL10, IFNG
2defense response to protozoanGO:00428329.9SLC11A1, IFNG
3negative regulation of growth of symbiont in hostGO:00441309.9IL10, IFNG
4protein import into nucleus, translocationGO:00000609.8SLC11A1, IFNG
5cellular response to lipopolysaccharideGO:00712229.7IL10, IFNG
6positive regulation of tyrosine phosphorylation of Stat1 proteinGO:00425119.7IFNG, IL21
7defense response to bacteriumGO:00427429.6SLC11A1, IL10, IFNG
8hemopoiesisGO:00300979.4DLL1, IL10
9positive regulation of T cell proliferationGO:00421029.4IL21, IFNG
10positive regulation of transcription from RNA polymerase II promoterGO:00459449.1IFNG, IL10, DLL1, SLC11A1
11inflammatory responseGO:00069548.9CXCR1, IL10, SLC11A1

Molecular functions related to Visceral Leishmaniasis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cytokine activityGO:00051259.1IL10, IL21, IFNG

Products for genes affiliated with Visceral Leishmaniasis

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies
  • Proteins
  • Kits and Assays

Sources for Visceral Leishmaniasis

About this section
3CDC
13ExPASy
14FMA
22GTR
23HGMD
24HMDB
25ICD10
26ICD10 via Orphanet
27ICD9CM
28IUPHAR
29KEGG
33MeSH
34MESH via Orphanet
35MGI
38NCIt
39NDF-RT
42NINDS
43Novoseek
45OMIM
46OMIM via Orphanet
50PubMed
51QIAGEN
56SNOMED-CT via Orphanet
60UMLS
61UMLS via Orphanet